NIPH Stock Overview
Develops, produces, and sells pharmaceutical products in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
EI- Nile Co. for Pharmaceuticals and Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م58.07 |
| 52 Week High | ج.م114.37 |
| 52 Week Low | ج.م49.00 |
| Beta | 0.18 |
| 11 Month Change | -36.89% |
| 3 Month Change | -14.59% |
| 1 Year Change | -33.48% |
| 33 Year Change | 103.18% |
| 5 Year Change | 159.59% |
| Change since IPO | 288.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 7.2% | -2.7% | -1.6% |
| 1Y | -33.5% | 25.3% | 26.5% |
Return vs Industry: NIPH underperformed the EG Pharmaceuticals industry which returned 28.5% over the past year.
Return vs Market: NIPH underperformed the EG Market which returned 27.8% over the past year.
Price Volatility
| NIPH volatility | |
|---|---|
| NIPH Average Weekly Movement | 19.0% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in EG Market | 9.8% |
| 10% least volatile stocks in EG Market | 3.8% |
Stable Share Price: NIPH's share price has been volatile over the past 3 months compared to the EG market.
Volatility Over Time: NIPH's weekly volatility has increased from 11% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Eldin Hajjaj | www.nilepharma.com.eg |
EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers tablets, capsules, ampoules, powders, gels and creams, syrups, suppositories, lotions, shampoos, ointments, mouthwashes, powder solutions, and nasal and midodrine drops. It also exports its products to the countries in the Middle East.
EI- Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary
| NIPH fundamental statistics | |
|---|---|
| Market cap | ج.م587.96m |
| Earnings (TTM) | ج.م90.23m |
| Revenue (TTM) | ج.م1.14b |
6.5x
P/E Ratio0.5x
P/S RatioIs NIPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.14b |
| Cost of Revenue | ج.م890.14m |
| Gross Profit | ج.م252.44m |
| Other Expenses | ج.م162.21m |
| Earnings | ج.م90.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.91 |
| Gross Margin | 22.09% |
| Net Profit Margin | 7.90% |
| Debt/Equity Ratio | 122.7% |
How did NIPH perform over the long term?
See historical performance and comparisonDividends
6.4%
Current Dividend Yield42%
Payout RatioDoes NIPH pay a reliable dividends?
See NIPH dividend history and benchmarks| EI- Nile for Pharmaceuticals and Chemical Industries dividend dates | |
|---|---|
| Ex Dividend Date | Nov 19 2024 |
| Dividend Pay Date | Nov 21 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 0 days |
Does NIPH pay a reliable dividends?
See NIPH dividend history and benchmarks